Synergene Active Ingredients Pvt. Ltd. Revenue and Competitors

Synergene Active Ingredients Pvt. Ltd., incorporated in 2006, is a manufacturer and supplier of Active Pharmaceutical Ingredients (APIs) and Intermediates for a wide range of therapeutic categories.The therapeutic segments of focus include Anti-Fungal, Anti-Depressant, Anti-Migraine, Anti-Hypertensive,Anti-Glaucoma, Anti-Histaminic,Antibiotic, Analgesic, Premature Ejaculation and Nootropic. Synergene is one of the leading manufacturers in Asia for Terbinafine Hydrochloride, Fluconazole, Voriconazole and Escitalopram Oxalate. It has CEP for the products, Terbinafine Hydrochloride and Fluconazole. EU Written Confirmation is available for Fluconazole, Terbinafine Hydrochloride, Escitalopram Oxalate,Losartan Potassium and Dapoxetine Hydrochloride. Synergene has been granted process patents for Luliconazole, Dapoxetine Hydrochloride and Escitalopram Oxalate. Synergene manufacturing facilities are cGMP compliant meeting applicable regulatory standards in terms of Infrastructure and Quality Management Systems. The company has three manufacturing facilities, one in Hyderabad and the other two in Vishakhapatnam. It acquired Jaahnavee Life Sciences Pvt. Ltd. at Visakhapatnam in 2018. Synergene Unit II , Visakhapatnam has been inspected and approved by the USFDA in 2016.